Results 231 to 240 of about 1,171,277 (292)

The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review. [PDF]

open access: yesRheumatology (Oxford)
Tarasconi E   +8 more
europepmc   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Juan de Luque‐Fernández   +5 more
wiley   +1 more source

Prevalence and Risk Factors of Systemic Lupus Erythematosus in Patients With Chronic Cutaneous Lupus: A Bicentric Study Employing Three Classification Criteria

open access: yesInternational Journal of Dermatology, EarlyView.
This bicentric study of 95 CCLE patients shows SLE prevalence (21.1%–31.6%) varies significantly by classification criteria. Arthralgia was a consistent independent risk factor across all systems. Our findings support the implementation of systematic risk‐stratified screening protocols for CCLE patients, with particular attention to joint symptoms and ...
Noureddine Litaiem   +4 more
wiley   +1 more source

Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia. [PDF]

open access: yesRes Pract Thromb Haemost
Zhai X   +17 more
europepmc   +1 more source

Immune effector cell‐associated neurotoxicity syndrome (ICANS) during tebentafusp in metastatic uveal melanoma

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Laura Schreieder   +7 more
wiley   +1 more source

Thrombocytopenia in Pregnancy: A 5‐Year Analysis of Characteristics and Practices From a Tertiary Academic Center

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley   +1 more source

Response to: citation clarification regarding feline eltrombopag in the ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats. [PDF]

open access: yesJ Vet Intern Med
LeVine DN   +24 more
europepmc   +1 more source

A practical approach to immune thrombocytopenia in pregnancy. [PDF]

open access: yesHematology Am Soc Hematol Educ Program
Matusiak K, Malinowski AK, Arnold DM.
europepmc   +1 more source

Dilution‐Endpoint Comparison of a Flow Cytometric Platelet Activation Assay With PF4/Heparin ELISA and a Lateral Flow Immunoassay in Suspected HIT

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Heparin‐induced thrombocytopenia (HIT) is a rare but potentially life‐threatening, immune‐mediated adverse reaction to heparin. PF4‐dependent immunoassays are sensitive screening tests, but they detect both platelet‐activating and nonactivating antibodies; therefore, positive results require interpretation in clinical context and,
Elvira Maličev   +4 more
wiley   +1 more source

Severe Thrombocytopenia Associated With Glucagon‐Like‐1 Receptor Agonists (GPL‐1RA): A SONAR Report

open access: yes
Diabetes, Obesity and Metabolism, EarlyView.
Charles L. Bennett   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy